文献速递肥胖与代谢综合征

袖状胃切除术在儿童及过渡期Prader-Willi综合征患者中的5年纵向研究

Sleeve gastrectomy in pediatric and transition age patients with Prader-Willi syndrome: a 5-year longitudinal study.
PubMed 文献 · J Clin Endocrinol Metab · 2026-01-01

单中心纵向回顾性队列研究纳入16例接受腹腔镜袖状胃切除术(LSG)的Prader-Willi综合征(PWS)患者、32例匹配的非综合征肥胖患者及16例仅生活方式干预的PWS患者。LSG可早期减重并部分维持,但长期获益较非综合征肥胖患者明显减弱。

要点

  • PWS患者LSG后5年ΔBMI-SDS%为-16.9%,远低于非综合征肥胖者的-57.4%。
  • 仅生活方式干预的PWS患者BMI-SDS%增加36.4%,合并症增多。

核心结论

  • PWS患者LSG可产生有临床意义的早期减重并在5年时部分维持,但长期获益较非综合征肥胖同龄人明显减弱。
  • 与单纯生活方式干预相比,LSG可改善PWS患者肥胖及心脏代谢合并症的进展轨迹。

研究设计与样本

  • 单中心、纵向、回顾性队列研究,共审查110例PWS患者和268例接受LSG受试者的电子健康记录。
  • 纳入16例接受LSG的PWS合并重度肥胖患者(PWS-LSG)和32例匹配的非综合征肥胖LSG患者(OB-LSG),以及16例仅接受生活方式干预的PWS患者(PWS-LS)。
  • 主要终点为5年时ΔBMI-SDS%。

主要发现

  • PWS-LSG组5年%BMI变化为-2.8%,绝对ΔBMI-SDS为-1.10。

临床怎么用

  • 对PWS合并重度肥胖的儿童及过渡期患者,LSG可作为改善长期体重轨迹和减少合并症的选项之一。
  • 应向患者及家属说明LSG在PWS中的长期减重效果较非综合征肥胖者弱,并强调术后持续随访。
  • 生活方式干预 alone 在PWS中与体重和合并症进展相关,支持在充分评估后考虑代谢手术。

局限性

  • 单中心、回顾性设计,样本量较小(PWS-LSG组16例,PWS-LS组16例)。
  • 非随机分组,可能存在选择偏倚和混杂因素。
  • 原文未报告更长随访时间及手术并发症数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the long-term effectiveness of laparoscopic sleeve gastrectomy (LSG) in pediatric and transition age patients with Prader-Willi syndrome (PWS). DESIGN: Single-center, longitudinal, retrospective cohort study. METHODS: We reviewed the electronic health records of 110 patients with PWS and 268 subjects undergoing LSG. We included 16 patients with PWS and severe obesity (PWS-LSG) and 32 matched non-syndromic patients with obesity (OB-LSG), both undergoing LSG, and 16 patients with PWS receiving lifestyle intervention only (PWS-LS). The primary endpoint was ΔBMI-SDS% at 5 years. RESULTS: In PWS-LSG, BMI-SDS decreased from 5.18 to an early nadir at 1-2 years (median ΔBMI-SDS% ∼-26%), then partially rebounded to 4.75 at 5 years, with ΔBMI-SDS% -16.9% (P = .012). Conventional metrics confirmed this attenuated response, with %BMI change -2.8% and absolute ΔBMI-SDS -1.10 at 5 years. In OB-LSG, BMI-SDS declined from 4.95 to 2.24, with larger and more sustained improvement (ΔBMI-SDS% -57.4%; P < .001 within-group; P = .002 vs PWS-LSG), corresponding to a %BMI change -40.1% and absolute ΔBMI-SDS -2.81 at 5 years. In PWS-LS, BMI-SDS increased from 2.25 to 3.19 (ΔBMI-SDS% + 36.4%, P = .003). The mean number of obesity-related comorbidities decreased in PWS-LSG (2.69 ± 1.66 to 1.94 ± 1.18; P = .041) and in OB-LSG (1.25 ± 0.88 to 0.56 ± 0.76; P < .001), but increased in PWS-LS (1.56 ± 0.96 to 2.44 ± 1.32; P = .004). CONCLUSION: In PWS, LSG produces clinically relevant early weight loss with partial maintenance at 5 years, but markedly attenuated long-term benefit compared with non-syndromic peers. Nevertheless, when interpreted against the progressive worsening of obesity and cardiometabolic comorbidities observed with lifestyle intervention alone, LSG appears to modify disease trajectory in PWS.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Aureli A, Carlomagno F, Crinò A, et al. Sleeve gastrectomy in pediatric and transition age patients with Prader-Willi syndrome: a 5-year longitudinal study. J Clin Endocrinol Metab. 2026. PMID: 42178926. doi:10.1210/clinem/dgag210

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。